- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Prostatic Neoplasms
Medical specialists from France tagged as investigators in clinical trials studying Prostatic Neoplasms
Total 332 results
-
Georges Fournier, MDSeen in:
- Brest, CHRU de Brest
- Brest, Department of Urology, Hopital de la Cavale Blanche
Trials:- NCT01221168 (Principal Investigator)
- NCT04745871 (Sub-Investigator)
Conditions: -
Gilles CALAISSeen in:
- Tours, CHRU Bretonneau
- Tours, CHU Tours - Hopital Bretonneau
Trials:- NCT04536805 (Principal Investigator)
- NCT03830788 (Principal Investigator)
Conditions: -
Gilles PASTICIER, MDSeen in:
- Bordeaux, Clinique Tivoli
- Bordeaux, Service d'Urologie, Clinique Tivoli Ducos
Trials:- NCT05710861 (Principal Investigator)
- NCT03568188 (Principal Investigator)
- NCT03531099 (Principal Investigator)
Conditions: -
Grégoire BOUCHESeen in:
- Reims, Institut Jean Godinot
Trials:- NCT04181203 (Principal Investigator)
- NCT03830788 (Principal Investigator)
Conditions: -
Guilhem RoubaudSeen in:
- Bordeaux Cedex, INSTITUT BERGONIE - Service d'Oncologie Médicale
- Bordeaux, Institut Bergonié
- Gironde, Bordeaux, Institut Bergonié
Trials:- NCT05327530 (Principal Investigator)
- NCT05848011 (Principal Investigator)
- NCT05551117 (Principal Investigator)
- NCT02869282 (Principal Investigator)
Conditions:- Locally Advanced or Metastatic Urothelial Carcinoma;
- Prostate Cancer Recurrent;
- Immunotherapy;
- Androgen-Independent Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Immune Checkpoint Inhibitor;
- Androgen-Independent Prostatic Neoplasms;
- Androgen-Insensitive Prostatic Cance;
- Inhibitory Checkpoint Molecule;
- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Anal Neoplasm;
- Prostate Cancer
-
Guillaume JANORAYSeen in:
- Tours, CHRU Henry S.Kaplan
Trials:- NCT03438552 (Principal Investigator)
Conditions: -
Guillaume MORICEAU, MDSeen in:
- Chambéry, CH Chambery
Trials:- NCT05739565 (Principal Investigator)
Conditions: -
Guillaume PLOUSSARDSeen in:
- Quint-Fonsegrives, Clinique La Croix du Sud
Trials:- NCT03088124 (Principal Investigator)
- NCT05710861 (Principal Investigator)
Conditions: -
Guillaume SERGENTSeen in:
- Sarcelles, Institut de Cancérologie Paris Nord
Trials:- NCT04181203 (Principal Investigator)
Conditions: -
Gwenaelle GravisSeen in:
- Bouches-du-Rhône, Marseille, Institut Paoli Calmettes - Hôpital de jour
- Marseille, Institut Paoli Calmettes - Hôpital de jour
- Provence-Alpes-Côte-d'Azur, Marseille, Institut Paoli-Calmettes
Trials:- NCT05288166 (Principal Investigator)
- NCT04601857 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6;
- Advanced and Metastatic Urothelial Cancer
-
Haixia YE, MDSeen in:
- Lyon, Hôpital Hédouard Herriot
Trials:- NCT03572621 (Sub-Investigator)
Conditions: -
Hakim FASSI-FEHRISeen in:
- Lyon, CHRU Hopital Edouard Herriot
- Lyon, HCL - Hôpital Edouard Herriot
- Lyon, Hôpital Hédouard Herriot
Trials:- NCT05739565 (Sub-Investigator)
- NCT03088124 (Sub-Investigator)
- NCT03572621 (Sub-Investigator)
Conditions: -
Harry TOLEDANO, MDSeen in:
- Marseille, APHM Nord Marseille
- Marseille, Service d'urologie Assistance Publique - Hôpitaux de Marseille - Hôpital Marseille Nord
Trials:- NCT05710861 (Principal Investigator)
- NCT03568188 (Principal Investigator)
- NCT03531099 (Principal Investigator)
Conditions: -
Henni Alexandre MedhiSeen in:
- Arras, Centre de radiotherapie Marie Curie
Trials:- NCT02799706 (Principal Investigator)
Conditions: -
Hervé LANG, MD, PhDSeen in:
- Strasbourg, Service d'Urologie - CHU de Strasbourg - France
Trials:- NCT06214000 (Principal Investigator)
Conditions: -
Hervé MONSAINT, MDSeen in:
- Vannes, Hôpital Privé Océane
Trials:- NCT04638088 (Principal Investigator)
Conditions: -
Ibrahim BAH-CLOZEL, MDSeen in:
- Guilherand-Granges, Hopital prive drome ardeche
Trials:- NCT05710861 (Principal Investigator)
Conditions: -
Igor LATORZEFFSeen in:
- Toulouse, Clinique Pasteur - ONCORAD
- Toulouse, Clinique Pasteur-Toulouse-Atrium
Trials:- NCT02799706 (Principal Investigator)
- NCT04181203 (Principal Investigator)
Conditions: -
Inès MENOUXSeen in:
- Strasbourg, Centre PAUL STRAUSS
Trials:- NCT04181203 (Principal Investigator)
Conditions: -
Jean-Baptiste GUY, MDSeen in:
- Valence, Centre Marie Curie
- Valence, Radiologie Drôme-Ardèche - Valence
Trials:- NCT04299646 (Principal Investigator)
- NCT05739565 (Principal Investigator)
Conditions: -
Jean-Baptiste Jean-Baptiste, MDSeen in:
- Strasbourg, ICANS - Institut de cancérologie Strasbourg Europe
Trials:- NCT04536805 (Principal Investigator)
Conditions:
Clinical Trials on Prostatic Neoplasms
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, AustraliaRecruitingCastration Resistant Prostatic CancerAustralia
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
Yinghao SunNot yet recruitingCastration-Resistant Prostatic Cancer
-
Institut Claudius RegaudWithdrawnProstatic Cancer, Castration-ResistantFrance
-
Rio de Janeiro State UniversityCompletedProstatic Cancer | Prostatic NeoplasmBrazil
-
Technische Universität DresdenRecruitingOligometastatic Disease | Prostatic Cancer, Castration-ResistantGermany
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Universität des SaarlandesRecruitingProstate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic CancerGermany
-
University Hospital, GrenobleTerminatedCastration-resistant Prostate CancerFrance
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingProstatic Neoplasms, Castration-Resistant | Prostatic Cancer, Castration-Resistant | Castration Resistant Prostatic Neoplasms | Androgen-Resistant Prostatic NeoplasmsUnited States, Canada